Skip to main content

Geovax Labs Inc WT(GOVXW-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

GeoVax to Present at the 2022 BIO CEO & Investor Digital Conference

Globe Newswire - Tue Feb 8, 2022

Atlanta, GA, Feb. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announced today that its Chairman and CEO, David Dodd, will present a company overview at the 2022 BIO CEO & Investor Digital Conference taking place February 14-17, 2022.

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe